Skip to content
GLP-1 Scorecard
Menu
Site position #429

Velvet Rx

Published by GLP-1 ScorecardUpdated

Velvet Rx advertises injectable semaglutide, injectable tirzepatide and oral GLP-1 options with $99, $179 and $149 advertised starting offers; the exact product and renewal terms require confirmation.

Our take

Velvet Rx has an attractive introductory offer, but I would put it behind a provider that clearly identifies the exact product and ongoing bill before intake. Its legal disclosures are more informative than the homepage; the remaining gap is connecting those disclosures to the plan being purchased.

Visit Velvet RxWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$99 advertised starting offer (renewal unverified)
Tirzepatide
$179 advertised starting offer (renewal unverified)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh Velvet Rx against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

The visible homepage advertises semaglutide from $99, tirzepatide from $179 and oral GLP-1 from $149. These minimum offers do not establish the ongoing renewal charge.

The introductory price is only the opening question

The homepage makes the opening offer easy to find, with injection and tablet options presented together. The harder question is what happens on the next charge: the terms leave subscription intervals to checkout and permit price changes. The minimum advertised amount is not a complete ongoing budget.

Do not multiply the headline discount by six to estimate a six-month budget. Obtain the renewal amount, medication quantity, billing interval and any dose-dependent change for the chosen package. If the supply is measured in weeks, establish how that relates to the charge dates rather than assuming calendar-month billing.

An ingredient name does not settle the product question

The homepage’s FDA-approved headline sits above semaglutide and tirzepatide offers without naming a branded injection. Its tablet description now says semaglutide or tirzepatide, which narrows the possibilities but still does not identify the particular formulation a patient would receive.

For a shopper specifically seeking a brand, that is not enough to choose this service. Confirm the product name, whether it is compounded and which pharmacy will dispense it. A broad headline should not substitute for the identity of the medicine in the actual order.

The company and pharmacy names are available

The terms identify Rocket Health Inc, give an Oceanside, California address and list RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx. They describe Rocket Health as the technology platform rather than the treating clinician. Those are useful disclosures, although the list does not map each pharmacy to each advertised treatment.

The same terms limit certain services by state despite a separate nationwide licensing statement. That means national licensing language should not be treated as proof that every product ships to every state. Resolve availability for the particular plan before beginning a transfer.

A discounted order is not automatically a refundable trial

The payment terms allow recurring charges and say processed orders or discounted services may be nonrefundable. They reference a separate billing and refund policy without supplying the full plan-specific cancellation answer in the reviewed text.

This review is based on public pages, without purchasing or testing support. The recommendation could improve with clear answers at checkout, but a shopper should not have to infer medication identity or renewal cost from a promotion. Until those points are settled, keep Velvet as a conditional comparison rather than the default choice.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value42/100
Dose & formulation75/100
Clinical oversight67/100
Labs & monitoring53/100
Fulfillment57/100
Contract terms55/100

Strengths

  • Advertises $99 semaglutide, $179 tirzepatide and $149 oral GLP-1 offers
  • Terms identify Rocket Health Inc and provide an Oceanside, California address
  • Names RedRock, Health Warehouse, Precision Compounding Pharmacy and Triad Rx in its pharmacy network
  • Lists injectable and oral treatment options

What to consider

  • Introductory amounts do not establish the ongoing charge or billing interval
  • The selected formulation and product-to-pharmacy assignment remain unconfirmed
  • State-specific product availability must be confirmed; a licensing statement is not a nationwide shipping guarantee
  • Processed or discounted orders may be nonrefundable under the published terms

Bottom line — Grade C

Best for: Self-pay shoppers willing to confirm the selected formulation, renewal terms and dispensing pharmacy before committing.

Look elsewhere if: Anyone seeking a clearly identified branded product or a fully verified ongoing price from the public offer alone.

Site position #429 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Velvet Rx — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Velvet Rx's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Velvet Rx's site. Not medical advice; see our disclosure.

← Back to the scorecard